Die Kosten für die Behandlung von Wilms-Tumor (Nephroblastom) in der Türkei variieren je nach Behandlungsplan und den spezifischen Bedürfnissen des Patienten. Ein PET-CT-Scan kostet 950 €. Chemotherapie-Sitzungen reichen von 2.470 € bis 10.740 €, abhängig von der Behandlungswoche. Ein Paket für autologe Stammzelltransplantation kostet 30.400 €. Der Behandlungsplan wird individuell nach einer umfassenden Bewertung durch das medizinische Team angepasst.
| Türkei | Österreich | Spanien | |
| Strahlentherapie bei Darmkrebs | von $7,000 | von $12,000 | von $10,000 |
| Chemotherapie bei Brustkrebs | von $1,200 | von $15,000 | von $3,500 |
Professor Ceyhun Bozkurt leitet die Klinik für pädiatrische Hämatologie und Onkologie im Medical Park Bahcelievler Hospital mit Fachkenntnissen auf dem Gebiet der Krebserkrankungen im Kindesalter.
Dr. Hasan Mutlu ist auf pädiatrische Onkologie spezialisiert, einschließlich der Behandlung von Wilms-Tumoren, und verfügt über eine internationale Ausbildung in medizinischer Onkologie.
Professor Dr. Yesim Yıldırım ist spezialisiert auf Krebsimmuntherapie und zielgerichtete Therapien am Anadolu Medical Center.
Dr. Ahmet Nadir Tosyali spezialisiert sich auf pädiatrische Onkologie und die Chirurgie von Wilms-Tumoren am Anadolu Medical Center.
Turkey is a primary destination for Wilms tumor treatment due to JCI-accredited hospitals and immediate access to care. Specialized centers provide comprehensive diagnostic protocols like scintigraphy. Families benefit from surgical oncology experts trained at leading international institutions. High-quality pediatric cancer care remains accessible without long waiting lists.
Bookimed Expert Insight: A major differentiator in Turkish oncology is the partnership with global leaders. For example, Anadolu Medical Center is affiliated with Johns Hopkins Hospital. This ensures pediatric protocols align with top US standards while maintaining the efficiency of private Istanbul centers. This synergy often results in a 90% success rate for complex transplant-related procedures.
Patient Consensus: Parents find that having a dedicated coordinator and airport pickup reduces the immense stress of a child's diagnosis. Many choose Turkey for a second opinion to verify staging before starting surgery or chemotherapy.
Turkish oncology centers report an 81.2% overall survival rate for Wilms tumor. Specialized facilities achieve success rates exceeding 90% for early-stage cases. Treatment involves multidisciplinary care. This includes surgery and chemotherapy. Leading hospitals maintain Joint Commission International accreditation for pediatric cancer protocols.
Bookimed Expert Insight: Success rates in Turkey are high because top centers mirror US protocols. Anadolu Medical Center is affiliated with Johns Hopkins Hospital. This connection ensures patients receive advanced oncology care. Most patients choose Istanbul centers. These hospitals serve over 65,000 international patients annually. This high volume builds significant surgical expertise in rare pediatric tumors.
Patient Consensus: Parents found the diagnostic process very thorough and fast. They appreciated that specialists explained every step of the complex treatment clearly.
The multidisciplinary plan for Wilms tumor involves pediatric oncologists, surgeons, and radiation specialists coordinating care. Treatment typically follows SIOP or COG protocols. These combine surgical nephrectomy with risk-stratified chemotherapy. Some cases require targeted radiation. This comprehensive approach yields 90% survival rates for localized cases.
Bookimed Expert Insight: Turkish oncology centers like Memorial Göztepe utilize multidisciplinary tumor boards for immediate case review. These boards often include surgeons like Dr. Murat Cakar who specializes in intra-abdominal cancer. This collaborative setting at JCI-accredited facilities ensures patients receive tailored plans combining surgery and systemic therapy.
Patient Consensus: Patients note it is important that all doctors are in one building. They feel more secure when the oncologists and surgeons work closely together.
Wilms tumor treatment in Turkey generally spans 3 to 12 months depending on the stage and pathology. A standard course includes diagnostic workups, surgical resection, and several chemotherapy cycles. Complex cases involving bilateral disease or metastasis often require extended radiation and systemic therapy protocols.
Bookimed Expert Insight: While many believe pediatric surgery is the longest phase, data from clinics like Memorial Şişli shows recovery is relatively quick. The real duration depends on pathology results, which dictate if chemotherapy lasts 18 or 30+ weeks. Experts like Dr. Murat Cakar at İstinye University Liv Hospital Topkapı often manage these long-term surgical and oncological transitions within one facility.
Patient Consensus: Parents note that treatment feels longer than expected due to waiting for pathology reports and subsequent follow-up scans. They appreciate that coordinators stay in touch throughout the many months of recurring oncology visits.